Strides Pharma gets USFDA nod for Tetracycline Hydrochloride Capsules; stock up 1%

The product will be manufactured at the companys flagship facility at Bangalore and will be marketed by Strides Pharma Inc. in the US market, the pharma company said in the filing.

from India Infoline News Service https://ift.tt/2wpehjG